Hansoh Pharmaceutical Group 配当と自社株買い
配当金 基準チェック /26
Hansoh Pharmaceutical Group配当を支払う会社であり、現在の利回りは2.09%で、収益によって十分にカバーされています。
主要情報
2.1%
配当利回り
0.04%
バイバック利回り
| 総株主利回り | 2.1% |
| 将来の配当利回り | 1.1% |
| 配当成長 | 53.0% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | HK$0.402 |
| 配当性向 | 40% |
最近の配当と自社株買いの更新
Recent updates
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Rather Sparingly
Nov 21
Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?
Nov 04Estimating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Aug 28Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now
Aug 07If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity
Jul 16Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 06Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
May 23Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 01Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?
Mar 28There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump
Mar 04An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued
Feb 16Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate
Oct 12Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's
Sep 14These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 10These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jan 23Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price
Oct 19Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued
Jun 09Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing
May 19Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?
Apr 22An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued
Feb 06決済の安定と成長
配当データの取得
安定した配当: 配当金の支払いは安定していますが、 3692が配当金を支払っている期間は 10 年未満です。
増加する配当: 3692の配当金は増加していますが、同社は4年間しか配当金を支払っていません。
配当利回り対市場
| Hansoh Pharmaceutical Group 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (3692) | 2.1% |
| 市場下位25% (HK) | 3.3% |
| 市場トップ25% (HK) | 8.1% |
| 業界平均 (Pharmaceuticals) | 3.8% |
| アナリスト予想 (3692) (最長3年) | 1.1% |
注目すべき配当: 3692の配当金 ( 2.09% ) はHong Kong市場の配当金支払者の下位 25% ( 3.3% ) と比べると目立ったものではありません。
高配当: 3692の配当金 ( 2.09% ) はHong Kong市場の配当金支払者の上位 25% ( 8.06% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: 3692の 配当性向 ( 39.6% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。
株主配当金
キャッシュフローカバレッジ: 3692は合理的な 現金配当性向 ( 52% ) を備えているため、配当金の支払いはキャッシュフローによって賄われます。